Age-specific risks of varicella complications
- PMID: 7243498
Age-specific risks of varicella complications
Abstract
Previous estimates of the age-specific risks of varicella-associated encephalitis and death (the only two varicella complications for which national data are available) have been based on age data for varicella cases from only three reporting areas. In an attempt to estimate more accurately the age-specific risks, 1978, age data for varicella cases were solicited from state epidemiologists. These age-specific data were compared to those from the three original reporting areas and from the National Center for Health Statistics Health Interview Survey (HIS) for the time period 1972 to 1978. The age distribution of state and HIS cases was then compared with that of encephalitis cases and deaths reported between 1972 and 1978 to the Centers for Disease Control and the National Center for Health Statistics, respectively. Despite differences in the number and distribution of varicella cases, both sources clearly identified those greater than or equal to 20 years of age as having the greatest risk of varicella encephalitis or death. Young children also were at increased risk. A number of problems with the reliability and accuracy of the data indicate that more specific data are needed to delineate further the groups most at risk of varicella complications who might benefit most from vaccination, and to evaluate accurately the effects the vaccine might have.
Similar articles
-
Severe complications of varicella in previously healthy children in Germany: a 1-year survey.Pediatrics. 2001 Nov;108(5):E79. Pediatrics. 2001. PMID: 11694663
-
Varicella mortality: trends before vaccine licensure in the United States, 1970-1994.J Infect Dis. 2000 Aug;182(2):383-90. doi: 10.1086/315714. Epub 2000 Jul 12. J Infect Dis. 2000. PMID: 10915066
-
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085. Pediatrics. 2006. PMID: 16740809
-
Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.J Clin Virol. 2005 Jun;33(2):89-95; discussion 96-8. doi: 10.1016/j.jcv.2005.02.003. J Clin Virol. 2005. PMID: 15911422 Review.
-
[Evaluation of varicella complications through a retrospective hospital survey in a paediatric center over 16 years in France].Arch Pediatr. 2004 Sep;11(9):1145-51. doi: 10.1016/j.arcped.2004.07.002. Arch Pediatr. 2004. PMID: 15351011 Review. French.
Cited by
-
Safety and Varicella Outcomes in In Utero-Exposed Newborns and Preterm Infants Treated With Varicella Zoster Immune Globulin (VARIZIG): A Subgroup Analysis of an Expanded-Access Program.J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):449-453. doi: 10.1093/jpids/piz070. J Pediatric Infect Dis Soc. 2020. PMID: 31774916 Free PMC article.
-
Clinical Manifestations of Varicella: Disease Is Largely Forgotten, but It's Not Gone.J Infect Dis. 2022 Oct 21;226(Suppl 4):S380-S384. doi: 10.1093/infdis/jiac390. J Infect Dis. 2022. PMID: 36265857 Free PMC article.
-
Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.BMC Med. 2022 Oct 8;20(1):387. doi: 10.1186/s12916-022-02534-7. BMC Med. 2022. PMID: 36209074 Free PMC article.
-
The age of infection with varicella-zoster virus in St Lucia, West Indies.Epidemiol Infect. 1993 Apr;110(2):361-72. doi: 10.1017/s0950268800068308. Epidemiol Infect. 1993. PMID: 8386097 Free PMC article.
-
Varicella-zoster virus.Clin Microbiol Rev. 1996 Jul;9(3):361-81. doi: 10.1128/CMR.9.3.361. Clin Microbiol Rev. 1996. PMID: 8809466 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Medical